Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
Protein

CD109 antigen

Gene

CD109

Organism
Homo sapiens (Human)
Status
Reviewed-Annotation score: Annotation score: 5 out of 5-Experimental evidence at protein leveli

Functioni

Modulates negatively TGFB1 signaling in keratinocytes.1 Publication

GO - Molecular functioni

GO - Biological processi

Complete GO annotation...

Keywords - Molecular functioni

Protease inhibitor, Serine protease inhibitor

Protein family/group databases

MEROPSiI39.006.

Names & Taxonomyi

Protein namesi
Recommended name:
CD109 antigen
Alternative name(s):
150 kDa TGF-beta-1-binding protein
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7
Platelet-specific Gov antigen
p180
r150
CD_antigen: CD109
Gene namesi
Name:CD109
Synonyms:CPAMD7
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640 Componenti: Chromosome 6

Organism-specific databases

HGNCiHGNC:21685. CD109.

Subcellular locationi

GO - Cellular componenti

  • anchored component of membrane Source: UniProtKB-KW
  • cell surface Source: UniProtKB
  • extracellular space Source: InterPro
  • plasma membrane Source: UniProtKB-SubCell
Complete GO annotation...

Keywords - Cellular componenti

Cell membrane, Membrane

Pathology & Biotechi

Organism-specific databases

Orphaneti853. Fetal and neonatal alloimmune thrombocytopenia.
PharmGKBiPA134949237.

Polymorphism and mutation databases

BioMutaiCD109.
DMDMi117949389.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Signal peptidei1 – 2121Add
BLAST
Chaini22 – 14201399CD109 antigenPRO_0000255945Add
BLAST
Propeptidei1421 – 144525Removed in mature formSequence AnalysisPRO_0000255946Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Glycosylationi68 – 681N-linked (GlcNAc...)2 Publications
Glycosylationi118 – 1181N-linked (GlcNAc...)2 Publications
Glycosylationi247 – 2471N-linked (GlcNAc...)2 Publications
Glycosylationi279 – 2791N-linked (GlcNAc...)Sequence Analysis
Glycosylationi365 – 3651N-linked (GlcNAc...)Sequence Analysis
Glycosylationi419 – 4191N-linked (GlcNAc...)2 Publications
Glycosylationi513 – 5131N-linked (GlcNAc...)PROSITE-ProRule annotation
Glycosylationi645 – 6451N-linked (GlcNAc...)Sequence Analysis
Cross-linki921 ↔ 924Isoglutamyl cysteine thioester (Cys-Gln)By similarity
Glycosylationi1086 – 10861N-linked (GlcNAc...)Sequence Analysis
Glycosylationi1355 – 13551N-linked (GlcNAc...)PROSITE-ProRule annotation
Lipidationi1420 – 14201GPI-anchor amidated alanineSequence Analysis

Post-translational modificationi

N-glycosylated.5 Publications
2 forms of 150 (p150) and 120 kDa (p120) exist due to proteolytic degradation from a 180 kDa form.

Keywords - PTMi

Disulfide bond, Glycoprotein, GPI-anchor, Lipoprotein, Thioester bond

Proteomic databases

MaxQBiQ6YHK3.
PaxDbiQ6YHK3.
PRIDEiQ6YHK3.

PTM databases

PhosphoSiteiQ6YHK3.

Expressioni

Tissue specificityi

Widely expressed with high level in uterus, aorta, heart, lung, trachea, placenta and in fetal heart, kidney, liver, spleen and lung. Expressed by CD34+ acute myeloid leukemia cell lines, T-cell lines, activated T-lymphoblasts, endothelial cells and activated platelets. Isoform 5 is expressed in placenta. Isoform 1 is expressed in keratinocytes and placenta.3 Publications

Gene expression databases

BgeeiQ6YHK3.
GenevisibleiQ6YHK3. HS.

Organism-specific databases

HPAiHPA009292.
HPA015113.

Interactioni

Subunit structurei

Heterodimer; disulfide-linked. Interacts with TGFB1 and TGFBR1. Forms a heteromeric complex with TGFBR1, TGFBR2 and TGFBR3 in a ligand-independent manner.1 Publication

Protein-protein interaction databases

BioGridi126424. 16 interactions.
IntActiQ6YHK3. 1 interaction.
STRINGi9606.ENSP00000287097.

Structurei

3D structure databases

ProteinModelPortaliQ6YHK3.
SMRiQ6YHK3. Positions 28-1418.
ModBaseiSearch...
MobiDBiSearch...

Family & Domainsi

Region

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Regioni593 – 702110Bait region (approximate)By similarityAdd
BLAST

Sequence similaritiesi

Keywords - Domaini

Bait region, Signal

Phylogenomic databases

eggNOGiCOG2373.
GeneTreeiENSGT00760000118982.
HOVERGENiHBG097839.
InParanoidiQ6YHK3.
KOiK06530.
OMAiMGSRIYQ.
OrthoDBiEOG7PGDPR.
PhylomeDBiQ6YHK3.
TreeFamiTF313285.

Family and domain databases

Gene3Di1.50.10.20. 1 hit.
2.60.40.690. 1 hit.
InterProiIPR009048. A-macroglobulin_rcpt-bd.
IPR011626. A2M_comp.
IPR002890. A2M_N.
IPR011625. A2M_N_2.
IPR014756. Ig_E-set.
IPR001599. Macroglobln_a2.
IPR019742. MacrogloblnA2_CS.
IPR019565. MacrogloblnA2_thiol-ester-bond.
IPR008930. Terpenoid_cyclase/PrenylTrfase.
[Graphical view]
PfamiPF00207. A2M. 1 hit.
PF07678. A2M_comp. 1 hit.
PF01835. A2M_N. 1 hit.
PF07703. A2M_N_2. 1 hit.
PF07677. A2M_recep. 1 hit.
PF10569. Thiol-ester_cl. 1 hit.
[Graphical view]
SUPFAMiSSF48239. SSF48239. 1 hit.
SSF49410. SSF49410. 1 hit.
SSF81296. SSF81296. 1 hit.
PROSITEiPS00477. ALPHA_2_MACROGLOBULIN. 1 hit.
[Graphical view]

Sequences (4)i

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

This entry describes 4 isoformsi produced by alternative splicing. AlignAdd to basket

Isoform 1 (identifier: Q6YHK3-1) [UniParc]FASTAAdd to basket

Also known as: CD109 180-kDa

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

« Hide

        10         20         30         40         50
MQGPPLLTAA HLLCVCTAAL AVAPGPRFLV TAPGIIRPGG NVTIGVELLE
60 70 80 90 100
HCPSQVTVKA ELLKTASNLT VSVLEAEGVF EKGSFKTLTL PSLPLNSADE
110 120 130 140 150
IYELRVTGRT QDEILFSNST RLSFETKRIS VFIQTDKALY KPKQEVKFRI
160 170 180 190 200
VTLFSDFKPY KTSLNILIKD PKSNLIQQWL SQQSDLGVIS KTFQLSSHPI
210 220 230 240 250
LGDWSIQVQV NDQTYYQSFQ VSEYVLPKFE VTLQTPLYCS MNSKHLNGTI
260 270 280 290 300
TAKYTYGKPV KGDVTLTFLP LSFWGKKKNI TKTFKINGSA NFSFNDEEMK
310 320 330 340 350
NVMDSSNGLS EYLDLSSPGP VEILTTVTES VTGISRNVST NVFFKQHDYI
360 370 380 390 400
IEFFDYTTVL KPSLNFTATV KVTRADGNQL TLEERRNNVV ITVTQRNYTE
410 420 430 440 450
YWSGSNSGNQ KMEAVQKINY TVPQSGTFKI EFPILEDSSE LQLKAYFLGS
460 470 480 490 500
KSSMAVHSLF KSPSKTYIQL KTRDENIKVG SPFELVVSGN KRLKELSYMV
510 520 530 540 550
VSRGQLVAVG KQNSTMFSLT PENSWTPKAC VIVYYIEDDG EIISDVLKIP
560 570 580 590 600
VQLVFKNKIK LYWSKVKAEP SEKVSLRISV TQPDSIVGIV AVDKSVNLMN
610 620 630 640 650
ASNDITMENV VHELELYNTG YYLGMFMNSF AVFQECGLWV LTDANLTKDY
660 670 680 690 700
IDGVYDNAEY AERFMEENEG HIVDIHDFSL GSSPHVRKHF PETWIWLDTN
710 720 730 740 750
MGYRIYQEFE VTVPDSITSW VATGFVISED LGLGLTTTPV ELQAFQPFFI
760 770 780 790 800
FLNLPYSVIR GEEFALEITI FNYLKDATEV KVIIEKSDKF DILMTSNEIN
810 820 830 840 850
ATGHQQTLLV PSEDGATVLF PIRPTHLGEI PITVTALSPT ASDAVTQMIL
860 870 880 890 900
VKAEGIEKSY SQSILLDLTD NRLQSTLKTL SFSFPPNTVT GSERVQITAI
910 920 930 940 950
GDVLGPSING LASLIRMPYG CGEQNMINFA PNIYILDYLT KKKQLTDNLK
960 970 980 990 1000
EKALSFMRQG YQRELLYQRE DGSFSAFGNY DPSGSTWLSA FVLRCFLEAD
1010 1020 1030 1040 1050
PYIDIDQNVL HRTYTWLKGH QKSNGEFWDP GRVIHSELQG GNKSPVTLTA
1060 1070 1080 1090 1100
YIVTSLLGYR KYQPNIDVQE SIHFLESEFS RGISDNYTLA LITYALSSVG
1110 1120 1130 1140 1150
SPKAKEALNM LTWRAEQEGG MQFWVSSESK LSDSWQPRSL DIEVAAYALL
1160 1170 1180 1190 1200
SHFLQFQTSE GIPIMRWLSR QRNSLGGFAS TQDTTVALKA LSEFAALMNT
1210 1220 1230 1240 1250
ERTNIQVTVT GPSSPSPVKF LIDTHNRLLL QTAELAVVQP TAVNISANGF
1260 1270 1280 1290 1300
GFAICQLNVV YNVKASGSSR RRRSIQNQEA FDLDVAVKEN KDDLNHVDLN
1310 1320 1330 1340 1350
VCTSFSGPGR SGMALMEVNL LSGFMVPSEA ISLSETVKKV EYDHGKLNLY
1360 1370 1380 1390 1400
LDSVNETQFC VNIPAVRNFK VSNTQDASVS IVDYYEPRRQ AVRSYNSEVK
1410 1420 1430 1440
LSSCDLCSDV QGCRPCEDGA SGSHHHSSVI FIFCFKLLYF MELWL
Length:1,445
Mass (Da):161,689
Last modified:October 31, 2006 - v2
Checksum:i0C5B1C3B8CCAF195
GO
Isoform 2 (identifier: Q6YHK3-2) [UniParc]FASTAAdd to basket

The sequence of this isoform differs from the canonical sequence as follows:
     93-169: Missing.

Note: No experimental confirmation available.
Show »
Length:1,368
Mass (Da):152,663
Checksum:i9F326D3F69033813
GO
Isoform 3 (identifier: Q6YHK3-3) [UniParc]FASTAAdd to basket

The sequence of this isoform differs from the canonical sequence as follows:
     658-665: AEYAERFM → LFGTQEAL
     666-1445: Missing.

Note: No experimental confirmation available.
Show »
Length:665
Mass (Da):74,411
Checksum:iCC73982C8E88647E
GO
Isoform 4 (identifier: Q6YHK3-4) [UniParc]FASTAAdd to basket

Also known as: CD109S

The sequence of this isoform differs from the canonical sequence as follows:
     1218-1234: Missing.

Show »
Length:1,428
Mass (Da):159,696
Checksum:i9DBA3F0AA03660F5
GO

Sequence cautioni

The sequence BAG53987.1 differs from that shown. Reason: Erroneous initiation. Curated
The sequence CAE46045.1 differs from that shown. Reason: Frameshift at position 1282. Curated
The sequence CAE46045.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened.Curated

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti627 – 6271M → I in AAN78483 (PubMed:14980714).Curated
Sequence conflicti789 – 7891K → E in BAG36395 (PubMed:14702039).Curated
Sequence conflicti803 – 8031G → S in AAN78483 (PubMed:14980714).Curated
Sequence conflicti1046 – 10461V → A in ABQ66266 (PubMed:17974005).Curated
Sequence conflicti1418 – 14181D → N in BAG53987 (PubMed:14702039).Curated

Polymorphismi

The Gov(b) variant in position 703 defines the Gov alloantigenic determinants.

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti45 – 451G → V.
Corresponds to variant rs9446983 [ dbSNP | Ensembl ].
VAR_028875
Natural varianti377 – 3771G → D.
Corresponds to variant rs7741152 [ dbSNP | Ensembl ].
VAR_048105
Natural varianti641 – 6411L → F.
Corresponds to variant rs7742662 [ dbSNP | Ensembl ].
VAR_048106
Natural varianti703 – 7031Y → S in allele Gov(b). 5 Publications
Corresponds to variant rs10455097 [ dbSNP | Ensembl ].
VAR_028876
Natural varianti797 – 7971N → S.4 Publications
Corresponds to variant rs2351528 [ dbSNP | Ensembl ].
VAR_028877
Natural varianti845 – 8451V → I.4 Publications
Corresponds to variant rs5023688 [ dbSNP | Ensembl ].
VAR_028878
Natural varianti1007 – 10071Q → E in a colorectal cancer sample; somatic mutation. 1 Publication
VAR_036236
Natural varianti1009 – 10091V → M.
Corresponds to variant rs35630075 [ dbSNP | Ensembl ].
VAR_048107
Natural varianti1065 – 10651N → K in a colorectal cancer sample; somatic mutation. 1 Publication
VAR_036237
Natural varianti1241 – 12411T → M.2 Publications
Corresponds to variant rs2917862 [ dbSNP | Ensembl ].
VAR_028879
Natural varianti1296 – 12961H → R.
Corresponds to variant rs13207595 [ dbSNP | Ensembl ].
VAR_048108

Alternative sequence

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Alternative sequencei93 – 16977Missing in isoform 2. 1 PublicationVSP_021312Add
BLAST
Alternative sequencei658 – 6658AEYAERFM → LFGTQEAL in isoform 3. 1 PublicationVSP_021313
Alternative sequencei666 – 1445780Missing in isoform 3. 1 PublicationVSP_021314Add
BLAST
Alternative sequencei1218 – 123417Missing in isoform 4. 1 PublicationVSP_021315Add
BLAST

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
AF410459 mRNA. Translation: AAL84159.1.
AY149920 mRNA. Translation: AAN78483.1.
AY788891 mRNA. Translation: AAX14639.1.
AK095888 mRNA. Translation: BAC04642.1.
AK123960 mRNA. Translation: BAG53987.1. Different initiation.
AK313636 mRNA. Translation: BAG36395.1.
AL834478 mRNA. Translation: CAD39137.1.
BX641095 mRNA. Translation: CAE46045.1. Sequence problems.
EF553520 mRNA. Translation: ABQ66266.1.
AL590428, AL591480 Genomic DNA. Translation: CAI15636.1.
AY736555 Genomic DNA. Translation: AAU94642.1.
AY736557 Genomic DNA. Translation: AAU94644.1.
AF410460 Genomic DNA. Translation: AAL84160.1.
CCDSiCCDS4982.1. [Q6YHK3-1]
CCDS55038.1. [Q6YHK3-4]
CCDS55039.1. [Q6YHK3-2]
RefSeqiNP_001153059.1. NM_001159587.2. [Q6YHK3-4]
NP_001153060.1. NM_001159588.2. [Q6YHK3-2]
NP_598000.2. NM_133493.4. [Q6YHK3-1]
XP_005248716.1. XM_005248659.2. [Q6YHK3-1]
UniGeneiHs.399891.

Genome annotation databases

EnsembliENST00000287097; ENSP00000287097; ENSG00000156535.
ENST00000422508; ENSP00000404475; ENSG00000156535. [Q6YHK3-2]
ENST00000437994; ENSP00000388062; ENSG00000156535. [Q6YHK3-4]
GeneIDi135228.
KEGGihsa:135228.
UCSCiuc003php.3. human. [Q6YHK3-1]
uc003phq.3. human. [Q6YHK3-4]
uc010kba.3. human. [Q6YHK3-2]

Keywords - Coding sequence diversityi

Alternative splicing, Polymorphism

Cross-referencesi

Web resourcesi

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
AF410459 mRNA. Translation: AAL84159.1.
AY149920 mRNA. Translation: AAN78483.1.
AY788891 mRNA. Translation: AAX14639.1.
AK095888 mRNA. Translation: BAC04642.1.
AK123960 mRNA. Translation: BAG53987.1. Different initiation.
AK313636 mRNA. Translation: BAG36395.1.
AL834478 mRNA. Translation: CAD39137.1.
BX641095 mRNA. Translation: CAE46045.1. Sequence problems.
EF553520 mRNA. Translation: ABQ66266.1.
AL590428, AL591480 Genomic DNA. Translation: CAI15636.1.
AY736555 Genomic DNA. Translation: AAU94642.1.
AY736557 Genomic DNA. Translation: AAU94644.1.
AF410460 Genomic DNA. Translation: AAL84160.1.
CCDSiCCDS4982.1. [Q6YHK3-1]
CCDS55038.1. [Q6YHK3-4]
CCDS55039.1. [Q6YHK3-2]
RefSeqiNP_001153059.1. NM_001159587.2. [Q6YHK3-4]
NP_001153060.1. NM_001159588.2. [Q6YHK3-2]
NP_598000.2. NM_133493.4. [Q6YHK3-1]
XP_005248716.1. XM_005248659.2. [Q6YHK3-1]
UniGeneiHs.399891.

3D structure databases

ProteinModelPortaliQ6YHK3.
SMRiQ6YHK3. Positions 28-1418.
ModBaseiSearch...
MobiDBiSearch...

Protein-protein interaction databases

BioGridi126424. 16 interactions.
IntActiQ6YHK3. 1 interaction.
STRINGi9606.ENSP00000287097.

Protein family/group databases

MEROPSiI39.006.

PTM databases

PhosphoSiteiQ6YHK3.

Polymorphism and mutation databases

BioMutaiCD109.
DMDMi117949389.

Proteomic databases

MaxQBiQ6YHK3.
PaxDbiQ6YHK3.
PRIDEiQ6YHK3.

Protocols and materials databases

DNASUi135228.
Structural Biology KnowledgebaseSearch...

Genome annotation databases

EnsembliENST00000287097; ENSP00000287097; ENSG00000156535.
ENST00000422508; ENSP00000404475; ENSG00000156535. [Q6YHK3-2]
ENST00000437994; ENSP00000388062; ENSG00000156535. [Q6YHK3-4]
GeneIDi135228.
KEGGihsa:135228.
UCSCiuc003php.3. human. [Q6YHK3-1]
uc003phq.3. human. [Q6YHK3-4]
uc010kba.3. human. [Q6YHK3-2]

Organism-specific databases

CTDi135228.
GeneCardsiGC06P074462.
H-InvDBHIX0006012.
HGNCiHGNC:21685. CD109.
HPAiHPA009292.
HPA015113.
MIMi608859. gene.
neXtProtiNX_Q6YHK3.
Orphaneti853. Fetal and neonatal alloimmune thrombocytopenia.
PharmGKBiPA134949237.
GenAtlasiSearch...

Phylogenomic databases

eggNOGiCOG2373.
GeneTreeiENSGT00760000118982.
HOVERGENiHBG097839.
InParanoidiQ6YHK3.
KOiK06530.
OMAiMGSRIYQ.
OrthoDBiEOG7PGDPR.
PhylomeDBiQ6YHK3.
TreeFamiTF313285.

Miscellaneous databases

ChiTaRSiCD109. human.
GeneWikiiCD109.
GenomeRNAii135228.
NextBioi83469.
PROiQ6YHK3.
SOURCEiSearch...

Gene expression databases

BgeeiQ6YHK3.
GenevisibleiQ6YHK3. HS.

Family and domain databases

Gene3Di1.50.10.20. 1 hit.
2.60.40.690. 1 hit.
InterProiIPR009048. A-macroglobulin_rcpt-bd.
IPR011626. A2M_comp.
IPR002890. A2M_N.
IPR011625. A2M_N_2.
IPR014756. Ig_E-set.
IPR001599. Macroglobln_a2.
IPR019742. MacrogloblnA2_CS.
IPR019565. MacrogloblnA2_thiol-ester-bond.
IPR008930. Terpenoid_cyclase/PrenylTrfase.
[Graphical view]
PfamiPF00207. A2M. 1 hit.
PF07678. A2M_comp. 1 hit.
PF01835. A2M_N. 1 hit.
PF07703. A2M_N_2. 1 hit.
PF07677. A2M_recep. 1 hit.
PF10569. Thiol-ester_cl. 1 hit.
[Graphical view]
SUPFAMiSSF48239. SSF48239. 1 hit.
SSF49410. SSF49410. 1 hit.
SSF81296. SSF81296. 1 hit.
PROSITEiPS00477. ALPHA_2_MACROGLOBULIN. 1 hit.
[Graphical view]
ProtoNetiSearch...

Publicationsi

« Hide 'large scale' publications
  1. "Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins."
    Lin M., Sutherland D.R., Horsfall W., Totty N., Yeo E., Nayar R., Wu X.-F., Schuh A.C.
    Blood 99:1683-1691(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 86-98; 127-137; 170-183; 185-196; 355-374; 413-425; 444-451; 465-471; 478-491; 494-510; 573-589; 649-655; 666-672; 677-683; 698-709 AND 791-806, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, VARIANT MET-1241.
  2. "CD109 represents a novel branch of the alpha2-macroglobulin/complement gene family."
    Solomon K.R., Sharma P., Chan M., Morrison P.T., Finberg R.W.
    Gene 327:171-183(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 22-50 (ISOFORM 1), TISSUE SPECIFICITY, VARIANTS SER-703; SER-797 AND ILE-845.
  3. "Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes."
    Finnson K.W., Tam B.Y.Y., Liu K., Marcoux A., Lepage P., Roy S., Bizet A.A., Philip A.
    FASEB J. 20:1525-1527(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), PROTEIN SEQUENCE OF 173-191, FUNCTION, INTERACTION WITH TGFB1 AND TGFBR1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, PROTEOLYTIC CLEAVAGE, VARIANTS SER-703; SER-797 AND ILE-845.
    Tissue: Placenta.
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), VARIANTS SER-703; SER-797 AND ILE-845.
    Tissue: Chondrocyte, Trachea and Vascular endothelial cell.
  5. Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANTS SER-703; SER-797; ILE-845 AND MET-1241.
    Tissue: Colon endothelium.
  6. "The DNA sequence and analysis of human chromosome 6."
    Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D.
    , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.
    Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  7. "CD109 defines an ancient branch of the alpha2M/C3, C4, C5 family."
    Prosper J.Y.A., Wu X.-F., Sutherland D.R., Irwin D.M., Schuh A.C.
    Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 370-444 AND 922-959.
  8. Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 703-741, VARIANT GOV(B) SER-703.
  9. "Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets."
    Sutherland D.R., Yeo E., Ryan A., Mills G.B., Bailey D., Baker M.A.
    Blood 77:84-93(1991) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEOLYTIC CLEAVAGE, GLYCOSYLATION.
  10. "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
    Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D.
    J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-68; ASN-118; ASN-247 AND ASN-419.
    Tissue: Plasma.
  11. "Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach."
    Lewandrowski U., Moebius J., Walter U., Sickmann A.
    Mol. Cell. Proteomics 5:226-233(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-247.
    Tissue: Platelet.
  12. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
    Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.
    J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-419.
    Tissue: Liver.
  13. "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."
    Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D.
    Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-68 AND ASN-118.
    Tissue: Leukemic T-cell.
  14. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  15. Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLU-1007 AND LYS-1065.

Entry informationi

Entry nameiCD109_HUMAN
AccessioniPrimary (citable) accession number: Q6YHK3
Secondary accession number(s): A5YKK4
, B2R948, B3KW25, Q0P6K7, Q5SYA8, Q5XUM7, Q5XUM9, Q6MZI7, Q8N3A7, Q8N915, Q8TDJ2, Q8TDJ3
Entry historyi
Integrated into UniProtKB/Swiss-Prot: October 31, 2006
Last sequence update: October 31, 2006
Last modified: July 22, 2015
This is version 96 of the entry and version 2 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Keywords - Technical termi

Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human cell differentiation molecules
    CD nomenclature of surface proteins of human leucocytes and list of entries
  2. Human chromosome 6
    Human chromosome 6: entries, gene names and cross-references to MIM
  3. Human entries with polymorphisms or disease mutations
    List of human entries with polymorphisms or disease mutations
  4. Human polymorphisms and disease mutations
    Index of human polymorphisms and disease mutations
  5. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  6. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3

Similar proteinsi

Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:
100%UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into Uniref entry.
90%UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence).
50%UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.